# Microvascular Flow Assessment Repeatability Study: The MARS Study

> **NCT01242020** · NA · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 6 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Perflutren Lipid Microsphere Injectable Suspension

## Key facts

- **NCT ID:** NCT01242020
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Unable to reliably reproduce, visualize, or quantify microvascular flow in the subcutaneous tissue, the skeletal muscle or peri-adventitia
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01242020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01242020, "Microvascular Flow Assessment Repeatability Study: The MARS Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01242020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*